#ELEG Electric Guitar PLC – Placing to raise £775,000 June 18, 2025 – Posted in: Electric Guitar Plc (ELEG)

The Board of Electric Guitar PLC (LSE: ELEG) is pleased to announce that it has raised £775,000 (before expenses) by way of a placing (the “Placing”) of a total of 968,750,000 new ordinary shares of 0.01 pence each in the Company (“Ordinary Shares”) at a price of 0.08 pence per new Ordinary Share (the “Issue Price”).   Transaction highlights ·      Placing to raise approximately £775,000 (before expenses) through the issue of 968,750,000 new Ordinary Shares…

Continue reading

#VELA investee co. #TRYB Tribe Technology PLC – Directorate Change January 11, 2024 – Posted in: Uncategorized

Tribe Technology PLC (AIM: TRYB), a disruptive developer and manufacturer of autonomous mining equipment, announces that Eric Hampel has notified the Company of his intention to step down as Chief Financial Officer (“CFO”) and as a director of the Company, due to personal circumstances. Eric will remain as CFO and as a director of the Company until July 2024. Eric will remain focused on running the Company’s finance function and continue to support Tribe Tech…

Continue reading

#VELA Vela Technologies PLC investee co. #ENSI Ensilica PLC – Unaudited Half Year Results February 17, 2023 – Posted in: Vela Technologies Plc (VELA)

EnSilica (AIM: ENSI), a leading mixed signal chipmaker, announces half year results for the six months ended 30 November 2022 (“H1 FY23”).   Financial Highlights   ·    Revenue up 23.5% to £8.6 million (H1 FY22: £7.0 million) ·    Adjusted operating profit up to £0.15 million (H1 FY22: £0.17 million loss) ·    Gross margin 42.5% (H1 FY22: 26.7%) ·    Adjusted EBITDA up significantly to £0.66 million (H1 FY22: loss of £0.08 million) ·    Cash and cash equivalents at 30 November of…

Continue reading

#VELA Vela Technologies PLC investee co. #KING Igraine PLC – Investment in Fixit Medical Ltd February 3, 2023 – Posted in: Vela Technologies Plc (VELA)

The Board of Igraine (AQSE:KING), an investing company focused on breakthrough innovative technologies and discoveries in the healthcare and life sciences sectors, announces a £100,000 cash investment into Fixit Medical Ltd (“Fixit”), the next generation drainage catheter fixation device. Further information on Fixit Fixit, a research and experimental development company focused on social sciences and humanities, is the sole owner, designer and developer of Cingo® (“Cingo”), the next drainage catheter fixation device. Cingo features best…

Continue reading

#VELA Vela Technologies Plc- Investee Company #MODE adds new tokens as it bolsters its crypto trading offering October 27, 2022 – Posted in: Vela Technologies Plc (VELA)

Mode Global Holdings PLC (LSE: MODE), the LSE-listed Fintech Group, is pleased to announce that it is adding new cryptoassets to the platform. Ethereum (ETH) is now available to buy and sell for all Mode app users, with Solana and Polkadot to follow in the following 2 weeks Up to ten new crypto assets will be added to the Mode platform in a phased approach, as previously confirmed by the FCA. Ethereum (ETH) will be…

Continue reading

#ZED Zenova Group Plc – Zenova FP approved by London Borough of Enfield November 8, 2021 – Posted in: Zenova Group Plc (ZED)

Zenova Group PLC (“Zenova”, the “Company” or the “Group”), a provider of innovative fire safety and heat management technology and products, is pleased to announce that its Zenova FP fire-resistant paint has been approved for use by the London Borough of Enfield, with its first utilisation to be in a fourteen-story residential tower block. Under local authority regulations, Zenova FP must be ‘specified’ for use as a fire protection product before contractors can use it…

Continue reading

LSE interview – Cathal Friel refocuses Open Orphan #ORPH as he raises 5m and buys virology specialist hVIVO February 7, 2020 – Posted in: Open Orphan (ORPH)

In a wide-ranging interview with London South East, Open Orphan Executive Chairman Cathal Friel outlines his vision for the business and explains how the combined talents of Open Orphan, hVivo and Venn Life Sciences will create a soon to be profitable pharmaceutical services one-stop shop. Friel says this acquisition is the last however, as he is a major shareholder and he doesn’t want to see his own shareholding diluted along with everyone elses. The focus…

Continue reading